Bavarian Nordic A/S (BVNRY)
OTCMKTS · Delayed Price · Currency is USD
9.79
-0.09 (-0.90%)
Nov 11, 2025, 2:07 PM EST
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of $2.31 billion as of November 12, 2025. Its market cap has decreased by -9.85% in one year.
Market Cap
2.31B
Enterprise Value
2.07B
Revenue
1.02B
Ranking
n/a
PE Ratio
10.30
Stock Price
$9.79
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 6.78M to 2.31B, an increase of 33,905.86%. That is a compound annual growth rate of 24.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 2.31B | 11.42% |
| Dec 30, 2024 | 2.07B | 0.95% |
| Dec 29, 2023 | 2.05B | -5.24% |
| Dec 30, 2022 | 2.16B | -24.82% |
| Dec 30, 2021 | 2.88B | 59.81% |
| Dec 30, 2020 | 1.80B | 116.49% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 679.77M |
| Glass House Brands | 625.26M |
| Northwest Biotherapeutics | 381.28M |
| American Oncology Network | 326.52M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 310.80M |
| CytoDyn | 308.64M |